ANI Pharmaceuticals Inc (ANIP)
54.16
-0.05
(-0.09%)
USD |
NASDAQ |
Dec 24, 16:00
ANI Pharmaceuticals Total Liabilities (Quarterly): 856.58M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Windtree Therapeutics Inc | 26.04M |
| Allogene Therapeutics Inc | 125.37M |
| AIM ImmunoTech Inc | 10.68M |
| Protalix BioTherapeutics Inc | 29.13M |
| Armata Pharmaceuticals Inc | 149.21M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.287B |
| Shareholders Equity (Quarterly) | 430.80M |
| Debt to Equity Ratio | 1.452 |
| Current Ratio | 2.745 |
| Net Debt Paydown Yield | -5.40% |